google-site-verification: googlec7193c3de77668c9.html

‘Certified safe’ personal care products may not undergo finished-product lab testing, analysis finds

[

personal care
Credit: ROMAN ODINTSOV from Pexels

None of the certification programs consumers rely on to find safer personal care products require laboratory testing of the products they certify, according to a new analysis. All judge chemical safety from ingredient lists and paperwork supplied by manufacturers, an approach that cannot catch contaminants, impurities or anything else that was never meant to be in the bottle.

The finding comes on the heels of a companion study that found unlabeled chemicals in nearly all 113 personal care and cleaning products tested. Most contained at least one unlabeled chemical with known or suspected health hazards, and one in four contained a chemical that contradicted claims on the package, including “phthalate-free” products that contained phthalates.

The research will be published in the journal Standards.

Paperwork over product testing

“Certification programs check the recipe. Nobody checks the cake,” said Johanna R. Rochester, lead author of the review and senior scientist at the Million Marker Research Institute. “What a company means to put in a product and what ends up in the bottle are two different things, and no one is checking the difference.”

The researchers reviewed 18 certification and ingredient-screening programs operating in U.S. and European markets, including third-party certifications such as MADE SAFE, Environmental Working Group, Cradle to Cradle, COSMOS, EU Ecolabel and EPA Safer Choice; retailer standards such as Clean at Sephora and Target Clean; and consumer scoring apps such as Yuka and Think Dirty.

Sixteen of the programs are designed to evaluate chemical hazards and were compared directly. None required routine analytical measurement of finished products. None used non-targeted analysis, a laboratory method that can screen for thousands of chemicals at once without a predefined list.

Six addressed contaminants or impurities as a defined category, and even then through ingredient restrictions or documentation rather than testing. A few require targeted testing for specific substances in specific situations, but that approach only finds chemicals that were anticipated in advance.

Regulators rely on the same model

Regulation follows the same pattern. Across U.S. federal and state laws in more than a dozen states, and under the European Union framework, chemical safety rests on ingredient restrictions, disclosure requirements and manufacturer documentation. Only a few states set concentration limits for a contaminant, such as the 1,4-dioxane limits in New York and Vermont.

The 2022 Modernization of Cosmetics Regulation Act expanded FDA authority over cosmetics but did not create a routine testing requirement. The EU requires a premarket safety assessment and a legally accountable person for each product, which is stronger oversight than the U.S. system, though it still focuses on known and declared substances.

Testing as a backstop

The authors propose adding analytical testing as a complementary layer to existing certification rather than replacing hazard screening. They suggest starting with voluntary programs and the highest-exposure categories, including products used by babies and pregnant women, leave-on products such as sunscreens and fragrances, and products used on sensitive areas such as feminine washes and menstrual products.

Non-targeted screening could be used for batch or periodic surveillance, with targeted follow-up testing to confirm and quantify anything of concern.

There is a business case as well. Between 2011 and 2023, 334 skin care products were recalled in the United States, covering more than 77 million units. Companies that certify products based on documentation alone remain exposed to recalls and litigation if later testing finds contamination.

“Shoppers read the label, look for the seal and still can’t know what’s in the bottle,” said Jenna Hua, senior author and founder of the Million Marker Research Institute. “Right now, the only way to know what’s in a product is to send it to a lab yourself. That’s an unfair thing to ask of a consumer, but it’s a reasonable thing to ask of a certifier.”

More information

Transparency Through Testing: Rethinking Certification and Safety in Personal Care Products, Standards (2026).

Key medical concepts

Laboratory TestsPhthalic Acids

Provided by
Million Marker Research Institute

Who’s behind this story?


Swati Mestri

Swati Mestri

Swati Mestri holds a bachelor’s degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space.

Full profile →

See also  Studies find time-release medication keeps adults with ADHD on track, lowers substance use risk

Advertisements

Robert Egan

Robert Egan

Bachelor’s in mathematical biology, Master’s in creative writing. Well-traveled with unique perspectives on science and language.

Full profile →

Citation:
‘Certified safe’ personal care products may not undergo finished-product lab testing, analysis finds (2026, August 25)
retrieved 25 August 2026
from https://medicalxpress.com/news/2026-08-certified-safe-personal-products-finished.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




Source link

See also  Conflict, climate threaten fight against diseases: Fund

Check Also

New philosophical framework reframes moral distress in health care

[ This type of suffering arises when professionals recognize the ethically appropriate course of action …

Monoclonal antibody targeting interleukin-6 achieves sustained reductions in inflammation biomarkers through six months

[ Credit: Unsplash/CC0 Public Domain The investigational anti-interleukin-6 (IL-6) monoclonal antibody pacibekitug produced sustained reductions …

Reducing antibiotic courses by two weeks could be possible in patients with infective endocarditis

[ Credit: Unsplash/CC0 Public Domain A response-tailored strategy reduced antibiotic duration by two weeks without …

Leave a Reply

Available for Amazon Prime